These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34900664)

  • 1. Identification of CCL4 as an Immune-Related Prognostic Biomarker Associated With Tumor Proliferation and the Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Zhang L; Zhang M; Wang L; Li J; Yang T; Shao Q; Liang X; Ma M; Zhang N; Jing M; Song R; Fan J
    Front Oncol; 2021; 11():694664. PubMed ID: 34900664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
    Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NUDT1 Could Be a Prognostic Biomarker and Correlated with Immune Infiltration in Clear Cell Renal Cell Carcinoma.
    Lin Y; Zhang F; Jin Y; Zhong Q; Tan W; Liu J; Wu Z
    Appl Bionics Biomech; 2022; 2022():3669296. PubMed ID: 36606241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PYCR1 regulates glutamine metabolism to construct an immunosuppressive microenvironment for the progression of clear cell renal cell carcinoma.
    Wei X; Zhang X; Wang S; Wang Y; Ji C; Yao L; Song N
    Am J Cancer Res; 2022; 12(8):3780-3798. PubMed ID: 36119844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
    Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
    Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC20 as a novel prognostic biomarker in ccRCC correlating with tumor immune microenvironment modulation.
    Xue B; Guo WM; Jia JD; Kadeerhan G; Liu HP; Bai T; Shao Y; Wang DW
    Am J Cancer Res; 2022; 12(2):695-712. PubMed ID: 35261796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a Novel Immune-Related Prognostic Biomarker and Small-Molecule Drugs in Clear Cell Renal Cell Carcinoma (ccRCC) by a Merged Microarray-Acquired Dataset and TCGA Database.
    Xiao GF; Yan X; Chen Z; Zhang RJ; Liu TZ; Hu WL
    Front Genet; 2020; 11():810. PubMed ID: 33014010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated X-C motif chemokine ligand 2 (XCL2) is associated with poor prognosis and increased immune infiltration in clear cell renal cell carcinoma.
    Cao Q; Liu D; Chen Z; Wang M; Wu M; Zeng G
    Cell Signal; 2023 Feb; 102():110556. PubMed ID: 36503163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly expressed of BID indicates poor prognosis and mediates different tumor microenvironment characteristics in clear cell renal cell carcinoma.
    Zeng J; Ke C; Tian K; Nie J; Huang S; Song X; Xian Z
    Discov Oncol; 2024 May; 15(1):176. PubMed ID: 38767695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics screening of prognostic immune-related genes in renal clear cell carcinoma.
    Cui K; Song H; Zhang H; Sun P
    J Appl Genet; 2024 May; ():. PubMed ID: 38780866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CXCR4 as a Prognostic Biomarker Associated With the Tumor Immune Microenvironment in Gastric Cancer.
    Gu Y; Gu W; Xie R; Chen Z; Xu T; Fei Z
    Front Cell Dev Biol; 2021; 9():654504. PubMed ID: 34568309
    [No Abstract]   [Full Text] [Related]  

  • 12. Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
    Meng L; Tian Z; Long X; Diao T; Hu M; Wang M; Zhang W; Zhang Y; Wang J; He Y
    Front Genet; 2020; 11():600248. PubMed ID: 33584797
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ma T; Meng L; Wang X; Tian Z; Wang J; Liu X; Zhang W; Zhang Y
    Am J Transl Res; 2021; 13(10):11048-11064. PubMed ID: 34786042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma.
    Lin MJ; Tang XX; Yao GS; Tan ZP; Dai L; Wang YH; Zhu JQ; Xu QH; Mumin MA; Liang H; Wang Z; Deng Q; Luo JH; Wei JH; Cao JZ
    Front Pharmacol; 2023; 14():1120562. PubMed ID: 37021054
    [No Abstract]   [Full Text] [Related]  

  • 15. Genomic Instability Promotes the Progression of Clear Cell Renal Cell Carcinoma Through Influencing the Immune Microenvironment.
    Wei X; Wang Y; Ji C; Luan J; Yao L; Zhang X; Wang S; Yao B; Qin C; Song N
    Front Genet; 2021; 12():706661. PubMed ID: 34712264
    [No Abstract]   [Full Text] [Related]  

  • 16. A signature based on m6A pattern and tumor microenvironment infiltration in clear cell renal cell carcinoma.
    Yang C; Yu T; Li Q; Xie F; Lin Q
    Am J Transl Res; 2022; 14(7):4931-4947. PubMed ID: 35958449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC).
    Liu S; Wang F; Tan W; Zhang L; Dai F; Wang Y; Fan Y; Yuan M; Yang D; Zheng Y; Deng Z; Liu Y; Cheng Y
    Cancer Cell Int; 2020; 20():519. PubMed ID: 33117084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of alternative polyadenylation regulators of CTLA4 and immune infiltration in clear cell renal cell carcinoma.
    Zhou M; Long W; Xiong M; Zhang F; Chen L; Chen J; Pang Z; Hou T; Li W
    Transl Androl Urol; 2023 Apr; 12(4):533-548. PubMed ID: 37181233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.
    Zhang Y; Hua X; Shi H; Zhang L; Xiao H; Liang C
    Cancer Cell Int; 2021 Dec; 21(1):680. PubMed ID: 34923969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of metabolic and immune profile as a prognostic indicator in patients with diabetic clear cell renal cell carcinoma.
    Cheng X; Hou Y
    Front Oncol; 2023; 13():1280618. PubMed ID: 37927470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.